BXM Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
BXM Wealth's BMY Position: Q2 2026 in Review
BXM Wealth opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 5,350 shares worth $308K. The stake represents 0.17% of the portfolio and ranks #128 among its holdings. This is a return to the name: BXM Wealth previously reported a position in BMY as recently as Q3 2025.
BXM Wealth first reported a position in BMY in Q3 2025 and has held it in 2 quarters since. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- BXM Wealth held 5,350 shares of Bristol-Myers Squibb worth $308K as of Q2 2026.
- Bristol-Myers Squibb was a new BXM Wealth position in Q2 2026.
- Bristol-Myers Squibb made up 0.17% of BXM Wealth's portfolio in Q2 2026, its #128 holding.
- BXM Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 2 quarters since.
- 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on BXM Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.